01 01
04 04

Product center

· Recombinant Human Growth Hormone (HGH) API
· Ademetionine1,4-Butanedisulfonate (SAM)

· Ademetionine1,4-Butanedisulfonate (SAM)

R & D

· Technology Platform
· Technology Team

· Scientific Research Results

Cooperation

NEWS CENTER

Qijian Bio Participates in EXPOFARMA 2026 in Mexico, Expanding Opportunities in the Latin American Pharmaceutical Market

Release Time：2026-04-16
From April 15 to 17, 2026, Jilin Qijian Bio-pharmaceutical Co., Ltd. participated in EXPOFARMA 2026 in Mexico City, further expanding its presence in the Latin American pharmaceutical market. During the exhibition, Qijian Bio engaged with industry professionals and business representatives across the pharmaceutical sector, and showcased its capabilities in Somatropin, Semaglutide, and GM-1 (Monosialotetrahexosylganglioside Sodium). The company also held in-depth discussions with customers and partners on API supply, formulation cooperation, registration support, and international market development. Among the products presented, Somatropin API attracted particular attention. Qijian Bio’s manufacturing system, quality management, and international compliance experience were well recognized by visitors and potential partners. Through EXPOFARMA, the company further strengthened its brand presence in Latin America and created new opportunities for future cooperation. Looking ahead, Qijian Bio will continue to advance its international development strategy, participate in global pharmaceutical exhibitions, and work with partners worldwide to support the development of the healthcare industry.
Qijian Bio Participates in EXPOFARMA 2026 in Mexico, Expanding Opportunities in the Latin American Pharmaceutical Market

Qijian Bio Goes Global at IPHEB 2026 in Russia

Release Time：2026-04-09
April 7–9, 2026 | St. Petersburg, Russia From April 7 to 9, 2026, Jilin Qijian Bio-pharmaceutical Co., Ltd. participated in IPHEB 2026 in St. Petersburg, Russia, presenting its core technologies and products in the fields of recombinant proteins and peptides at the ExpoForum Convention and Exhibition Centre. As a biopharmaceutical company from China, Qijian Bio used this exhibition to strengthen its international presence and showcase the capabilities of Chinese biopharmaceutical innovation and manufacturing. During the event, Qijian Bio met with pharmaceutical professionals, business partners, and potential customers from around the world, creating new opportunities for international cooperation. Through its participation in IPHEB 2026, Qijian Bio continues to expand its global reach and explore new partnerships in the international pharmaceutical market. Exhibition Venue ExpoForum Convention and Exhibition Centre Peterburgskoye Shosse 64/1, St. Petersburg, Russia Exhibition Dates April 7–9, 2026 Qijian Bio welcomes pharmaceutical industry professionals and partners worldwide to connect with us and explore future cooperation.
Qijian Bio Goes Global at IPHEB 2026 in Russia

Jilin Qijian Bio-Pharmaceutical Co., Ltd. participated in the 2023CPHI Southeast Asia Exhibition

Release Time：2023-07-17
CPHI South East Asia 2023 has been held at Queen Sirikit National Convention Center, Bangkok, Thailand from July 12-14, 2023.
Jilin Qijian Bio-Pharmaceutical Co., Ltd. participated in the 2023CPHI Southeast Asia Exhibition

Legal Statement

Release Time：2022-10-31
We solemnly declare: Registered Chinese website of our company: www.qjbio.com.cn， Registered English website of our company：www.qijianbio.com, Contact information Phone: 0086-431-81285900 Fax: 0086-431-88794098 Mobile: 0086-18543117394 E-mail: export@qijianbio.com Furthermore, our company does not register or use other websites, and we also don’t authorize anyone to register or use other websites. Please distinguish truth from falsehood, beware of being cheated!
Legal Statement

Qijian Bio-pharmaceutical made a major breakthrough in the R&D of key transdermal technology using HGH analogue peptides as raw materials for medical beauty products, laying a good foundation for the company to expand the medical beauty industry in 2021.

Release Time：2021-12-01
Qijian Bio-pharmaceutical made a major breakthrough in the R&D of key transdermal technology using HGH analogue peptides as raw materials for medical beauty products, laying a good foundation for the company to expand the medical beauty industry in 2021.
Qijian Bio-pharmaceutical made a major breakthrough in the R&D of key transdermal technology using HGH analogue peptides as raw materials for medical beauty products, laying a good foundation for the company to expand the medical beauty industry in 2021.

About Us

Qijian Bio-Pharmaceutical Co., Ltd was founded in 2005, located in No.707 Chaofan street, Changchun High-Tech Industrial Development Zone, Qijian  has been created by several overseas returned Doctors. Qijian is a national high-tech enterprise with professional research and development......

Culture

>

Honor

>

Development

>

Enterprise Style

>

Copyright：Jilin Qijian Bio-pharmaceutical Co., Ltd.
吉ICP备20003293号  by:300.cn